OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Erba Discusses the Frontline Treatment of CML

March 28th 2012

Dr. Harry Erba, from the University of Michigan Health System, Discusses the Frontline Treatment of CML

Dr. Ellis Describes Breast Cancer Heterogeneity

March 27th 2012

Dr. Matthew Ellis, from Siteman Cancer Center, Describes Breast Cancer Heterogeneity

Dr. Spector Discusses the Complexities of Cancer

March 26th 2012

Dr. Neil Spector, from the Duke Cancer Institute, Discusses the Complexities of Cancer

Dr. Dunleavy Discusses ABC DLBCL Research

March 23rd 2012

Dr. Kieron Dunleavy, from the National Cancer Institute, Discusses ABC DLBCL Research

Dr. Davidson Discusses Breast Cancer Chemoprevention

March 23rd 2012

Dr. Nancy Davidson, from the University of Pittsburgh Cancer Institute, Discusses Breast Cancer Chemoprevention

Dr. Chang on Combining HER2 Targeted Therapies

March 22nd 2012

Dr. Jenny Chang, from the Methodist Cancer Center, Discusses Combining HER2 Targeted Therapies

Dr. Gore on Hypofractionated Radiation Therapy

March 22nd 2012

Dr. Elizabeth Gore, from the Medical College of Wisconsin, Discusses Hypofractionated Radiotherapy

Dr. Borgen on the Negative Effects of Pinkwashing

March 20th 2012

Dr. Patrick Borgen, from the Maimonides Breast Cancer Center, Discusses the Negative Effects of Pinkwashing

Dr. Wierda Discusses Watchful Waiting in CLL

March 14th 2012

Dr. William Wierda, from the MD Anderson Cancer Center, Discusses Watchful Waiting in CLL

Dr. Perez-Soler on the Future of Lung Cancer Therapies

March 13th 2012

Dr. Roman Perez-Soler, from Albert Einstein College of Medicine, on the Future of Lung Cancer Therapies

Dr. Jagannath Discusses the VANTAGE Trials

March 12th 2012

Dr. Sundar Jagannath, from Mount Sinai Medical Center, Discusses the VANTAGE Trials

Dr. Schnabel Discusses the DCIS Recurrence Score

March 9th 2012

Dr. Freya Schnabel from NYU School of Medicine Discusses the DCIS Recurrence Score

Dr. Harvey Discusses Preventing Breast Cancer

March 8th 2012

Dr. Harold Harvey from Penn State Hershey Cancer Institute Discusses Preventing Breast Cancer

Dr. Ansell on Waldenstrom Macroglobulinemia Symptoms

March 8th 2012

Dr. Stephen Ansell from the Mayo Clinic in Minnesota Describes Waldenstrom Macroglobulinemia Symptoms

Dr. Belani Discusses Driver Mutations in NSCLC

March 7th 2012

Dr. Chandra Belani from Penn State Hershey Cancer Institute Discusses Driver Mutations in NSCLC

Dr. Ramaswamy Discusses Tumor Heterogeneity

March 7th 2012

Dr. Sridhar Ramaswamy from the Massachusetts General Hospital Cancer Center Discusses Tumor Heterogeneity

Dr. Baselga Discusses the BOLERO Breast Cancer Trials

March 5th 2012

Dr. Jose Baselga from Massachusetts General Hospital Discusses the BOLERO Breast Cancer Trials

Dr. William Wierda Discusses Diagnosing CLL

March 5th 2012

Dr. William Wierda, from MD Anderson Cancer Center, on Diagnosing Chronic Lymphocytic Leukemia

Dr. Mesa Discusses JAK Inhibitors for Myelofibrosis

March 2nd 2012

Dr. Ruben Mesa from the Mayo Clinic in Arizona Discusses JAK Inhibitors for Myelofibrosis

Dr. Birrer on the Ovarian Cancer Avastin OS Benefit

March 2nd 2012

Dr. Michael Birrer from Massachusetts General Hospital Cancer Center on the Ovarian Cancer Avastin OS Benefit